OZAWADE

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug OZAWADE contains one active pharmaceutical ingredient (API):

1	Pitolisant UNII YV33CH63HI - PITOLISANT HYDROCHLORIDE
	Pitolisant is a potent, orally active histamine H3-receptor antagonist/inverse agonist which, via its blockade of histamine auto-receptors enhances the activity of brain histaminergic neurons, a major arousal system with widespread projections to the whole brain. Pitolisant also modulates various neurotransmitter systems, increasing acetylcholine, noradrenaline and dopamine release in the brain.
	Read more about Pitolisant

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OZAWADE Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N07XX11		N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1858642, 1858653, 1858664
FR	Base de données publique des médicaments	60227166, 61247435
IT	Agenzia del Farmaco	049682014, 049682026, 049682038, 049682040
LT	Valstybinė vaistų kontrolės tarnyba	1093277, 1093278, 1093279
PL	Rejestru Produktów Leczniczych	100459920, 100459937